Precision Biologic

Precision BioLogic develops, manufactures and markets innovative products for the clinical laboratory assessment of blood coagulation disorders. Our principal focus is in the field of hemostasis, for which we developed CRYOcheck, a line of specialized, high-quality frozen plasmas, reagents and integrated test kits used in the assessment of hemostasis. Precision currently serves over clinical laboratories throughout North America with direct overnight delivery and works with distribution partners to sell to customers overseas. In November 2018, we acquired Affinity Biologicals, a primary manufacturer of thrombosis and hemostasis products, enabling us to expand our clinical and research offerings to include an extensive line of coagulation-related antibodies as well as other products and services. Most recently, in October 2025, we acquired George King Bio-Medical, a provider of hemostasis diagnostic products with close ties to the bleeding disorders community. All three organizations are committed to delivering high-quality products and services backed by knowledgeable, caring professionals.